Active Trading Blog

Too Many Unknowns, Not Enough Knowns

By: Spencer Israel On February 12, 2002, Secretary of Defense Donald Rumsfeld was asked during a press conference about whether there was evidence of weapons of mass destruction in Iraq. This was his response: “Reports that say that something hasn’t happened are always interesting to me, because as we know, there are known knowns; there.. Read more

The Economic Data Is Coming, And It’s Going To Be Bad

By: Spencer Israel If the U.S. economy was a movie, then Thursday gave us our first teaser trailer.  And it was bad.  By now, you know the number. A record 3.28 million Americans filed for unemployment benefits during the week of March 20, a 1,100% increase from the previous week. And that is just the.. Read more

The IPOX® Week, March 30, 2020

IPOX® Indexes rise sharply after U.S. Futures and Option expiration as massive global stimulus outweigh COVID-19. IPOX® Global Alternative Strategy on course for best quarterly performance on record. IPO Deal-flow Review & Outlook: Much anticipated cancer drugs developer InnoCare Pharma (9969 HK) surges in H.K. trading debut. Quiet April ahead from global New Listings. IPOX®.. Read more

On Ups And Downs In Volatile Markets

By: Spencer Israel Call it human nature, or call it people trying to do their best Mark Haines impression. But for whatever reason, everybody wants to be the one to call the bottom.  Last week, as Bill Ackman’s emotional appearance on CNBC coincided with a new low for the day, the “Ackman Bottom” was coined.. Read more

The IPOX® Week, March 23, 2020

IPOX® International (ETF: FPX) outperforms as IPOX Europe (IXTE) gains. Another rough week for U.S. equities. Amid huge moves in global equity indexes spreads, IPOX Global Alternative Strategy soars +4.47% +25.39% YTD. IPO Deal-flow Review & Outlook: Asset Manager Ninety One (N91 LN) completes London Spin-off. Hong Kong awaits hot InnoCare Pharma (9969 HK) IPO... Read more

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.